To catalogue

EXCIPRESS™ SD2L

CAS Number
63-42-3
EC Number
200-559-2
Chemical Name
Lactose

EXCIPRESS™ SD2L is a spray dried lactose typically used for direct compression. It is manufactured under GMP standards and conforms to Ph.Eur, USP NF and JP lactose monohydrate monographs. Spray dried lactose consists of fine primary lactose particles bound in a matrix of amorphous lactose, It combines high compaction properties of fine lactose crystals and amorphous lactose & very good flowability of spherical particles.

Properties

Physical Form
  • Powder
  • Solid
Pharma and Nutraceuticals Functions
Compression Aid

Product families

Applications

Healthcare & Pharma — Drug Delivery & Care Solutions
  • Oral

Product Families

Pharmaceuticals & Nutraceuticals — Excipients
  • Formulation & Processing Aids

Other characteristics

Brand
EXCIPRESS
Functions
Compression Aid
Dosage Form
  • Capsules, Sachets, Tablets
  • Capsules
  • Sachets
  • Tablets
Certifications & Compliance

European Pharmacopeia (Ph. Eur.), GMP, ISO 22000, ISO 9001, Japan Pharmacopeia (JP), National Formulary (NF), United States Pharmacopeia (USP)

Grade
Pharma Grade
Markets
Healthcare & Pharma
Appearance
White crystalline powder
Shelf LIfe
18 Months
Soluble In
Water
Insoluble In
Ethanol (96%)
Key Benefits

Excellent compaction properties; Very good flowability; Very good blending properties (Low dose formulations)

Technology
Pharmaceuticals & Nutraceuticals
Benefit Claims
Excellent Flowability
Certifications
  • EXCIPACT certified (GMP)
  • ISO 9001 and ISO 22000 certified
  • Following IPEC cGMP
  • On-site Batch testing & Batch release
  • Certified animal Rennet-free raw materials
Packaging Type
Bags
Residual Solvents

No class 1, 2, 3 solvents are used during production. (CPMP/ICH/283/95 + CVMP/VICH/502/99)

Storage Information

Store in original unopened packaging, in a dry and odor free place.

Manufacturing Technology
Direct Compression
Certifications and Compliance
  • European Pharmacopeia (Ph. Eur.)
  • GMP
  • ISO 22000
  • ISO 9001
  • Japan Pharmacopeia (JP)
  • National Formulary (NF)
  • United States Pharmacopeia (USP)

Technical data

Table 1 of 1

16 rows
CharacteristicValueUnitMethod
Absorbance (Proteins and Light Absorbing Impurities, [A] 1%, 1 cm at 210 to 220 nm)max. 0.25——
Absorbance (Proteins and Light Absorbing Impurities, [A] 1%, 1 cm at 270 to 300 nm)max. 0.07——
Absorbance (Proteins and Light Absorbing Impurities, [A] 10%, 1 cm at 400 nm)max. 0.04——
Acidity or Alkalinity (at ml 0.1 M NaOH)max. 0.4——
Escherichia ColiNegativein 1g—
Heavy Metalsmax. 5ppmUSP
Loss on Dryingmax. 0.5%—
Particle Size Distribution (max. 100 µm)30 - 65%Air Jet Sieve
Particle Size Distribution (max. 250 µm)min. 95%Air Jet Sieve
Particle Size Distribution (max. 45 µm)max. 15%Air Jet Sieve
Residue on Ignition / Sulphated Ashmax. 0.1%—
SalmonellaNegativein 10g—

The Omnichem website uses cookies. By continuing to use the site, you consent to their use in accordance with our Privacy Policy and to the collection of analytics.